| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| 1 | AN ACT concerning regulation.
| |||||||||||||||||||
| 2 | Be it enacted by the People of the State of Illinois,
| |||||||||||||||||||
| 3 | represented in the General Assembly:
| |||||||||||||||||||
| 4 | Section 5. The Illinois Insurance Code is amended by | |||||||||||||||||||
| 5 | changing Section 356z.4 as follows:
| |||||||||||||||||||
| 6 | (215 ILCS 5/356z.4)
| |||||||||||||||||||
| 7 | Sec. 356z.4. Coverage for contraceptives.
| |||||||||||||||||||
| 8 | (a) The General Assembly hereby finds and declares all of | |||||||||||||||||||
| 9 | the following: | |||||||||||||||||||
| 10 | (1) Illinois has a long history of expanding timely | |||||||||||||||||||
| 11 | access to birth control to prevent unintended pregnancy. | |||||||||||||||||||
| 12 | (2) The federal Patient Protection and Affordable Care | |||||||||||||||||||
| 13 | Act includes a contraceptive coverage guarantee as part of | |||||||||||||||||||
| 14 | a broader requirement for health insurance to cover key | |||||||||||||||||||
| 15 | preventive care services without out-of-pocket costs for | |||||||||||||||||||
| 16 | patients. | |||||||||||||||||||
| 17 | (3) The General Assembly intends to build on existing | |||||||||||||||||||
| 18 | State and federal law to promote gender equity and women's | |||||||||||||||||||
| 19 | health and to ensure greater contraceptive coverage equity | |||||||||||||||||||
| 20 | and timely access to all federal Food and Drug | |||||||||||||||||||
| 21 | Administration approved methods of birth control for all | |||||||||||||||||||
| 22 | individuals covered by an individual or group health | |||||||||||||||||||
| 23 | insurance policy in Illinois. | |||||||||||||||||||
| |||||||
| |||||||
| 1 | (4) Medical management techniques such as denials, | ||||||
| 2 | step therapy, or prior authorization in public and private | ||||||
| 3 | health care coverage can impede access to the most | ||||||
| 4 | effective contraceptive methods. | ||||||
| 5 | (b) As used in this Section: | ||||||
| 6 | "Contraceptive services" includes consultations, | ||||||
| 7 | examinations, procedures, and medical services, provided on an | ||||||
| 8 | outpatient basis and related to the use of contraceptive | ||||||
| 9 | methods (including natural family planning) to prevent an | ||||||
| 10 | unintended pregnancy. | ||||||
| 11 | "Medical necessity" includes, but is not limited to, | ||||||
| 12 | considerations such as severity of side effects, differences in | ||||||
| 13 | permanence and reversibility of contraceptive, and ability to | ||||||
| 14 | adhere to the appropriate use of the item or service, as | ||||||
| 15 | determined by the attending provider. | ||||||
| 16 | "Therapeutic equivalent version" means drugs, devices, or | ||||||
| 17 | products that can be expected to have the same clinical effect | ||||||
| 18 | and safety profile when administered to patients under the | ||||||
| 19 | conditions specified in the labeling and satisfy the following | ||||||
| 20 | general criteria: | ||||||
| 21 | (1) they are approved as safe and effective; | ||||||
| 22 | (2) they are pharmaceutical equivalents in that they | ||||||
| 23 | (A) contain identical amounts of the same active drug | ||||||
| 24 | ingredient in the same dosage form and route of | ||||||
| 25 | administration and (B) meet compendial or other applicable | ||||||
| 26 | standards of strength, quality, purity, and identity; | ||||||
| |||||||
| |||||||
| 1 | (3) they are bioequivalent in that (A) they do not | ||||||
| 2 | present a known or potential bioequivalence problem and | ||||||
| 3 | they meet an acceptable in vitro standard or (B) if they do | ||||||
| 4 | present such a known or potential problem, they are shown | ||||||
| 5 | to meet an appropriate bioequivalence standard; | ||||||
| 6 | (4) they are adequately labeled; and | ||||||
| 7 | (5) they are manufactured in compliance with Current | ||||||
| 8 | Good Manufacturing Practice regulations. | ||||||
| 9 | (c) (a) An individual or group policy of accident and | ||||||
| 10 | health insurance amended,
delivered, issued, or renewed in this | ||||||
| 11 | State after the effective date of this amendatory Act of the | ||||||
| 12 | 99th General Assembly shall provide coverage for all of the | ||||||
| 13 | following services and contraceptive methods: | ||||||
| 14 | (1) All contraceptive drugs, devices, and other | ||||||
| 15 | products approved by the United States Food and Drug | ||||||
| 16 | Administration. This includes all over-the-counter | ||||||
| 17 | contraceptive drugs, devices, and products approved by the | ||||||
| 18 | United States Food and Drug Administration. The following | ||||||
| 19 | apply: | ||||||
| 20 | (A) If the United States Food and Drug | ||||||
| 21 | Administration has approved one or more therapeutic | ||||||
| 22 | equivalent versions of a contraceptive drug, device, | ||||||
| 23 | or product, a policy is not required to include all | ||||||
| 24 | such therapeutic equivalent versions in its formulary, | ||||||
| 25 | so long as at least one is included and covered without | ||||||
| 26 | cost-sharing and in accordance with this Section. | ||||||
| |||||||
| |||||||
| 1 | (B) If an individual's attending provider | ||||||
| 2 | recommends a particular service or item approved by the | ||||||
| 3 | United States Food and Drug Administration based on a | ||||||
| 4 | determination of medical necessity with respect to | ||||||
| 5 | that individual, the plan or issuer must cover that | ||||||
| 6 | service or item without cost sharing. The plan or | ||||||
| 7 | issuer must defer to the determination of the attending | ||||||
| 8 | provider. | ||||||
| 9 | (C) If a drug, device, or product is not covered, | ||||||
| 10 | plans and issuers must have an easily accessible, | ||||||
| 11 | transparent, and sufficiently expedient process that | ||||||
| 12 | is not unduly burdensome on the individual or a | ||||||
| 13 | provider or other individual acting as a patient's | ||||||
| 14 | authorized representative to ensure coverage without | ||||||
| 15 | cost sharing. | ||||||
| 16 | (D) This coverage must provide for the dispensing | ||||||
| 17 | of 12 months' worth of contraception at one time. | ||||||
| 18 | (2) Voluntary sterilization procedures. | ||||||
| 19 | (3) Contraceptive services, patient education, and | ||||||
| 20 | counseling on contraception. | ||||||
| 21 | (4) Follow-up services related to the drugs, devices, | ||||||
| 22 | products, and procedures covered under this Section, | ||||||
| 23 | including, but not limited to, management of side effects, | ||||||
| 24 | counseling for continued adherence, and device insertion | ||||||
| 25 | and removal. | ||||||
| 26 | (d) A policy subject to this Section shall not impose a | ||||||
| |||||||
| |||||||
| 1 | deductible, coinsurance, copayment, or any other cost-sharing | ||||||
| 2 | requirement on the coverage provided pursuant to this Section. | ||||||
| 3 | (e) Except as otherwise authorized under this Section, a | ||||||
| 4 | policy shall not impose any restrictions or delays on the | ||||||
| 5 | coverage required under this Section. | ||||||
| 6 | this
amendatory Act of the 93rd General Assembly that provides | ||||||
| 7 | coverage for
outpatient services and outpatient prescription | ||||||
| 8 | drugs or devices must provide
coverage for the insured and any
| ||||||
| 9 | dependent of the
insured covered by the policy for all | ||||||
| 10 | outpatient contraceptive services and
all outpatient | ||||||
| 11 | contraceptive drugs and devices approved by the Food and
Drug | ||||||
| 12 | Administration. Coverage required under this Section may not | ||||||
| 13 | impose any
deductible, coinsurance, waiting period, or other | ||||||
| 14 | cost-sharing or limitation
that is greater than that required | ||||||
| 15 | for any outpatient service or outpatient
prescription drug or | ||||||
| 16 | device otherwise covered by the policy. (b) As used in this | ||||||
| 17 | Section, "outpatient contraceptive service" means
| ||||||
| 18 | consultations, examinations, procedures, and medical services, | ||||||
| 19 | provided on an
outpatient basis and related to the use of | ||||||
| 20 | contraceptive methods (including
natural family planning) to | ||||||
| 21 | prevent an unintended pregnancy.
| ||||||
| 22 | (f) (c) Nothing in this Section shall be construed to | ||||||
| 23 | require an insurance
company to cover services related to an | ||||||
| 24 | abortion as the term "abortion" is
defined in the Illinois | ||||||
| 25 | Abortion Law of 1975.
| ||||||
| 26 | (d) Nothing in this Section shall be construed to require | ||||||
| |||||||
| |||||||
| 1 | an insurance
company to cover services related to permanent | ||||||
| 2 | sterilization that requires a
surgical procedure.
| ||||||
| 3 | (Source: P.A. 95-331, eff. 8-21-07.)
| ||||||